ANXA1 and prostate cancer: Here, we proposed a hypothesis that TRPM7 might respond to hypoxia to regulate the degradation of HIF-1α, and thus to control its downstream target, Annexin A1, and subsequently to affect the hypoxia-induced aggressive ability of androgen-independent prostate cancer cells.